192 related articles for article (PubMed ID: 34904712)
1. Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions.
Gruber VE; Luinenburg MJ; Colleselli K; Endmayr V; Anink JJ; Zimmer TS; Jansen F; Gosselaar P; Coras R; Scholl T; Blumcke I; Pimentel J; Hainfellner JA; Höftberger R; Rössler K; Feucht M; van Scheppingen J; Aronica E; Mühlebner A
Epilepsia; 2022 Feb; 63(2):364-374. PubMed ID: 34904712
[TBL] [Abstract][Full Text] [Related]
2. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
Nguyen LH; Mahadeo T; Bordey A
J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
[TBL] [Abstract][Full Text] [Related]
3. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
[TBL] [Abstract][Full Text] [Related]
4. The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia.
Hulshof HM; Benova B; Krsek P; Kyncl M; Lequin MH; Belohlavkova A; Jezdik P; Braun KPJ; Jansen FE
Epilepsia Open; 2021 Dec; 6(4):663-671. PubMed ID: 34328682
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
[TBL] [Abstract][Full Text] [Related]
6. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
Sarnat HB; Flores-Sarnat L
Brain Dev; 2015 Jun; 37(6):553-62. PubMed ID: 25451314
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
8. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
[TBL] [Abstract][Full Text] [Related]
9. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
[TBL] [Abstract][Full Text] [Related]
10. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
Zimmer TS; Ciriminna G; Arena A; Anink JJ; Korotkov A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Baayen JC; Idema S; Rensing NR; Wong M; Mills JD; van Vliet EA; Aronica E
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431
[TBL] [Abstract][Full Text] [Related]
11. Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies.
Gruber VE; Lang J; Endmayr V; Diehm R; Pimpel B; Glatter S; Anink JJ; Bongaarts A; Luinenburg MJ; Reinten RJ; van der Wel N; Larsen P; Hainfellner JA; Rössler K; Aronica E; Scholl T; Mühlebner A; Feucht M
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):812-825. PubMed ID: 34173252
[TBL] [Abstract][Full Text] [Related]
12. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
[TBL] [Abstract][Full Text] [Related]
14. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
[TBL] [Abstract][Full Text] [Related]
15. Cell injury and premature neurodegeneration in focal malformations of cortical development.
Iyer A; Prabowo A; Anink J; Spliet WG; van Rijen PC; Aronica E
Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
Wong M
Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
[TBL] [Abstract][Full Text] [Related]
17. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
[TBL] [Abstract][Full Text] [Related]
18. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Huang K; Wang Z; He Z; Li Y; Li S; Shen K; Zhu G; Liu Z; Lv S; Zhang C; Yang H; Yang X; Liu S
Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030
[TBL] [Abstract][Full Text] [Related]
19. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
